Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital upgrades Lloyds to 'outperform' on Supreme Court ruling

(Sharecast News) - RBC Capital Markets upgraded Lloyds Banking Group on Monday to 'outperform' from 'sector perform' after the Supreme Court ruled largely in favour of banks in the car finance case. "We see Friday's Supreme Court judgement as a clearing event for the bank and expect the FCA to take a moderate approach when laying out its final redress scheme towards the end of this year," it said.

RBC said that in valuation terms, Lloyds looks relatively fairly valued, however it thinks the stock should trade at a premium to peers for a number of factors.

"We like: (i) the strength of the bank's deposit franchise, (ii) earnings sustainability driven by the structural hedge, and (iii) a relatively attractive total return yield," RBC said.

"It's hard to see LLOY underperforming into the medium term given rate expectations and a softening regulatory backdrop."

RBC said it's around 8% ahead of consensus earnings per share by FY27E and 15% ahead on distributions.

The bank kept its price target at 95p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.